The safety of systemic Janus kinase inhibitors in atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials. | 2024 | Journal of the European Academy of Dermatology and Venereology |
Improvement in work productivity among psoriatic arthritis patients treated with biologic or targeted synthetic drugs: a systematic literature review and meta-analysis. | 2024 | Arthritis Therapy & Research |
Safety of upadacitinib in immune-mediated inflammatory diseases: systematic literature review of indirect and direct treatment comparisons of randomized controlled trials. | 2024 | Advances in Therapy |
Comparing binary efficacy outcomes for systemic immunomodulatory treatments for atopic dermatitis in a living systematic review and network meta-analysis. | 2024 | British Journal of Dermatology |
Effectiveness of systemic treatments on pruritus associated with atopic dermatitis: a systematic review in pediatric patients. | 2024 | Pediatric Dermatology |
Elevation of creatine phosphokinase in moderate-severe atopic dermatitis is associated with the use of JAK inhibitors but not dupilumab: a systematic review and meta-analysis. | 2024 | Journal of American Academy of Dermatology |
Practical use of upadacitinib in patients with severe atopic dermatitis in a real-world setting: a systematic review. | 2024 | Clinical, Cosmetic, and Investigational Dermatology |
Janus kinase inhibitors in atopic dermatitis: an umbrella review of meta-analyses. | 2024 | Frontiers in Immunology |
Comparative maintenance performance of all biologic agents and small molecules in ulcerative colitis: a network meta-analysis. | 2024 | European Journal of Gastroenterology & Hepatology |
Janus kinase inhibitors and adverse events of acne: a systematic review and meta-analysis. | 2023 | JAMA Dermatology |
Systemic treatments for atopic dermatitis (eczema): systematic review and network meta-analysis of randomized trials. | 2023 | Journal of Allergy and Clinical Immunology |
Short-term efficacy and safety of biologics and Janus kinase inhibitors for patients with atopic dermatitis: a systematic review and meta-analysis. | 2023 | Heliyon |
Reproductive safety issues of novel small molecules for the treatment of inflammatory bowel disease: a systematic review. | 2023 | Journal of Clinical Medicine |
Upadacitinib in crohn’s disease: a comprehensive systematic review of efficacy and safety. | 2023 | Cureus |
Efficacy and safety of abrocitinib and upadacitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a systematic review and meta-analysis. | 2023 | Heliyon |
Efficacy of biological therapies and small molecules in induction and maintenance of remission in luminal Crohn’s disease: systematic review and network meta-analysis. | 2023 | Gut |
The efficacy and safety of biologic drugs in the treatment of moderate-severe Crohn’s disease: a systematic review. | 2023 | Pharmaceuticals |
Comparative efficacy and safety of bimekizumab in axial spondyloarthritis: a systematic literature review and network meta-analysis. | 2023 | Rheumatology |
Comparative of the effectiveness and safety of biological agents, small molecule drugs, and microbiome therapies in ulcerative colitis: Systematic review and network meta-analysis. | 2023 | Medicine Open |
Association of risk of incident acne and treatment with systemic Janus kinase inhibitors in atopic dermatitis: a systematic review and meta-analysis. | 2023 | Inflammation Research |
Comparative speed of early symptomatic remission with advanced therapies for moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis. | 2023 | American Journal of Gastroenterology |
Efficacy and safety of Janus kinase inhibitors in patients with psoriasis and psoriatic arthritis: a systematic review and meta-analysis. | 2023 | Clinical Rheumatology |
Impact of upadacitinib on the risk of digestive events in patients with rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials. | 2023 | Heliyon |
The comparative efficacy and safety of biologics and small molecules for treating patients with ulcerative colitis in Portugal: a systematic literature review and network meta-analysis. | 2023 | European Review for Medical and Pharmacological Science |
Comparative onset of effect of biologics and small molecules in moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis. | 2023 | EClinicalMedicine |
Oral Janus kinase inhibitors in the treatment of atopic dermatitis: a systematic review and meta-analysis. | 2023 | Skin Health and Disease |
Are Janus kinase inhibitors safe and effective in treating the key clinical domains of psoriatic arthritis? A systematic review and meta-analysis. | 2023 | International Journal of Rheumatic Diseases |
Systemic immunomodulatory treatments for atopic dermatitis update of a living systematic review and network meta-analysis. | 2022 | JAMA Dermatology |
Association between Janus kinase inhibitors therapy and mental health outcome in rheumatoid arthritis: a systematic review and meta-analysis. | 2022 | Rheumatology and Therapy |
The safety of systemic Janus kinase inhibitors in atopic dermatitis: a systematic review and network meta analysis. | 2022 | European Journal of Clinical Pharmacology |
Long-term effectiveness and safety of biologic and small molecule drugs for moderate to severe atopic dermatitis: a systematic review. | 2022 | Life |
Comparative effectiveness of guselkumab in psoriatic arthritis: updates to a systematic literature review and network meta-analysis. | 2022 | Rheumatology |
Comparative efficacy and safety of abrocitinib, baricitinib, and upadacitinib for moderate-to-severe atopic dermatitis: a network meta-analysis. | 2022 | Dermatologic Therapy |
Comparative efficacy of targeted systemic therapies for moderate to severe atopic dermatitis without topical corticosteroids: systematic review and network meta-analysis. | 2022 | Dermatology and Therapy |
Comparative efficacy and safety of Janus kinase inhibitors and secukinumab in patients with active ankylosing spondylitis: a systematic review and meta-analysis. | 2022 | Pharmacology |
Association of risk of incident venous thromboembolism with atopic dermatitis and treatment with Janus kinase inhibitors: a systematic review and meta-analysis. | 2022 | JAMA Dermatology |
Efficacy and safety of JAK inhibitors in the treatment of psoriasis and psoriatic arthritis: a systematic review and meta-analysis. | 2022 | BMC Rheumatology |
Comparative efficacy and safety of monoclonal antibodies and janus kinase inhibitors in moderate-to-severe atopic dermatitis: a systematic review and meta-analysis. | 2022 | Acta Dermato-venereologica |
Efficacy of biologics and oral small molecules for atopic dermatitis: a systematic review and meta-analysis. | 2022 | Journal of Dermatological Treatment |
Efficacy and safety of Janus kinase inhibitors for the treatment of atopic dermatitis: a systematic review and meta-analysis. | 2022 | Dermatology |
Comparative efficacy and safety of systemic therapies used in moderate-to-severe atopic dermatitis: a systematic literature review and network meta-analysis. | 2021 | Journal of the European Academy of Dermatology and Venereology |
Systemic treatments in the management of atopic dermatitis: a systematic review and meta-analysis. | 2021 | European Journal of Allergy and Clinical Immunology |
Short-term effectiveness and safety of biologics and small molecule drugs for moderate to severe atopic dermatitis: a systematic review and network meta-analysis. | 2021 | Life |
Comparative efficacy and safety of Janus kinase inhibitors and biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and network meta-analysis. | 2021 | Therapeutic Advances in Musculoskeletal Disease |
Systematic review on the efficacy and safety of oral Janus kinase inhibitors for the treatment of atopic dermatitis. | 2021 | Frontiers in Medicine |
The efficacy of Janus kinase inhibitors in patients with atopic dermatitis: a systematic review and network meta-analysis. | 2021 | Dermatologic Therapy |
Efficacy and safety of Janus kinase inhibitors for the treatment of atopic dermatitis: a systematic review and meta-analysis. | 2021 | Dermatology |
Efficacy of biological therapies and small molecules in moderate to severe ulcerative colitis: systematic review and network meta-analysis. | 2021 | Gut |
Comparative efficacy and tolerability of Janus kinase inhibitor therapies for moderate to severe Crohn’s disease: α network meta-analysis. | 2021 | Journal of Gastrointestinal and Liver Diseases |
Biological therapies for atopic dermatitis: a systematic review. | 2021 | Dermatology |
Comparative efficacy and safety of 15 and 30 mg upadacitinib administered to patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials. | 2020 | Zeitschrift für Rheumatologie |
Efficacy and safety of tofacitinib, baricitinib, and upadacitinib for rheumatoid arthritis: a systematic review and meta-analysis. | 2020 | Mayo Clinic |
Comparative efficacy and safety of tofacitinib, baricitinib, upadacitinib, filgotinib and peficitinib as monotherapy for active rheumatoid arthritis. | 2020 | Journal of Clinical Pharmacy and Therapeutics |
Comparative efficacy of JAK inhibitors for moderate-to-severe rheumatoid arthritis: a network meta-analysis. | 2020 | Advances in Therapy |
Safety of Janus kinase inhibitors in patients with inflammatory bowel diseases or other immune-mediated diseases: a systematic review and meta-analysis. | 2020 | Gastroenterology |
Comparison of Janus kinase inhibitors in the treatment of rheumatoid arthritis: a systemic literature review. | 2019 | Immunotherapy |
Comparison of the efficacy and safety of tofacitinib and upadacitinib in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials. | 2019 | International Journal of Rheumatic Diseases |
A systematic review and meta-analysis of infection risk with small molecule JAK inhibitors in rheumatoid arthritis. | 2019 | Rheumatology |
Impact of Janus kinase inhibitors on risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials. | 2019 | Annals of Rheumatic Diseases |